Hematopoietic reconstitution after stem cell transplantation requires excessive replicative activity due to the limited number of stem cells that are used for transplantation. After bone marrow transplantation telomere shortening has been detected in hematopoietic cells. This has been interpreted to result from excessive replication of the stem cells, with putative concomitant reduction of their replicative potential. Nowadays, hematopoietic stem cells from cytokine-mobilized peripheral blood are increasingly used for stem cell transplantation. These grafts contain higher numbers of hematopoietic stem cells, resulting in a faster hematopoietic reconstitution.
Introduction
Telomeres are specialized structures at the ends of chromosomes 1;2 . Since somatic cells have a limited lifespan and their telomeres shorten with every cell cycle, it has been postulated that telomeres function as a mitotic clock 3 and that telomere length represents remaining replicative potential 4 . When telomeres reach a critical length, cells usually cease to divide and enter apoptosis.
Telomere length has been studied in patients after bone marrow transplantation (BMT). It was found that the telomere length of various hematopoietic cell subsets was reduced at several years after allogeneic stem cell transplantation [5] [6] [7] [8] [9] . This was suggested to be caused by the expansion of hematopoietic stem cells after transplantation, resulting in a stem cell pool with reduced telomere length that might not have the same regenerative capacity as the stem cell pool in a healthy individual.
This fuelled the concern about the long-term effects of transplantation and the possibility of long-term graft failure or clonal hematological disorders. We and others have reported that patients at several decades after transplantation exhibit no further shortening of telomere length [10] [11] [12] . This led to the notion that accelerated reduction of telomere length is a transient phenomenon and that after a period of accelerated shortening, telomeres reduce in length at the same rate as in healthy individuals [13] [14] [15] [16] .
Cytokine-mobilized peripheral blood is now being used as the preferred source of stem cells 17 .
The use of those cells for stem cell transplantation is associated with accelerated hematological reconstitution. This is believed to be related to the significantly higher numbers of stem cells in these grafts in comparison with a bone marrow graft [18] [19] [20] [21] [22] [23] [24] . While most studies of telomere dynamics after transplantation deal with transplantation of bone marrow, we here analyzed hematopoietic reconstitution and telomere dynamics in recipients of G-CSF-mobilized peripheral blood stem cell grafts. Our results indicate the occurrence of telomere length homeostasis rather than shortening during the immediate reconstitution phase.
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Material and Methods

Patients and donors
Patients eligible for allogeneic peripheral blood stem cell transplantation (alloPBSCT) from an HLA-matched related donor in our hospital as well as their donors were entered into the study according to a protocol approved by the institutional medical ethical committee. The patients followed a standard conditioning regimen consisting of cyclophosphamide for two consecutive days (60 mg/kg/day on day -6 and -5) followed by a single dose of total body irradiation (9 Gy on day -1).
Donors received rhG-CSF treatment (Filgrastim, Amgen, Thousand Oaks, CA, USA, 10 µg/kg/day on days -5 to -1) and underwent a large volume leukapheresis procedure to obtain a minimum number of 4 x 10 6 CD34+ cells/kg body weight of the recipient. The grafts were depleted for T-and B-cells by incubation with 10 mg Campath-1G or Campath-1H (humanized Campath-1) for 30 minutes at room temperature 18 .
Sample collection
20 ml of heparinized peripheral blood was collected from donors and recipients of a peripheral blood stem cell graft. Donors were sampled either before G-CSF administration or at least 3 months after transplantation. Recipients were sampled at 6 weeks, 3 months, 6 months, 9 months and 1 year after PBSCT. Patients with a relapse of the underlying disease went off study. (CLB, Amsterdam, The Netherlands). Analysis was performed on a FACS Calibur (BDIS). Absolute
Blood cell analysis
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Cell separation
Granulocytes and the mononuclear cell (MNC) fractions were isolated by standard density gradient separation and NH 4 , for the monocytes, B-cells and the T h cells, respectively. Subsets with a purity of less than 75% were excluded from further analysis.
DNA isolation
DNA was isolated from the separated cell fractions using a DNA isolation kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. After isolation, a 5% aliquot was separately frozen for chimerism analysis. The remaining 95% was either used immediately or frozen for future telomere length analysis.
Chimerism analysis
For gender-mismatched transplantations, chimerism was analyzed by fluorescence in situ hybridization (FISH) with X and Y chromosome-specific probes. For gender-matched transplantations, chimerism was analyzed by short tandem repeat analysis using informative markers out of an initial panel of 12 tetranucleotide repeat polymorphic sites (CSF, D3S1358, D5S818, D7S820, D13S317, P-labeled telomerespecific 5'(CCCTAA) 5 3' probe. After washes in decreasing concentrations of NaCl/Na-citrate, the membranes were exposed to a PhosphorImager plate (Molecular Dynamics, Sunnyvale, CA) and density profiles were generated using ImageQuant software (Molecular Dynamics). The median telomere length was calculated as L i at the median of (OD i /L i ) in the range 3-12 kb, where OD i is an individual optical density value and L i the corresponding fragment length.
Statistical analysis
Mixed model variance analysis was performed on the complete data set to identify trends and significant telomere length changes. In this model follow-up time was handled as a fixed factor and patient as a random factor and the covariance matrix was unspecified. The assumed normality was checked by visual inspection of the histogram of the residuals. Time points after transplantation were defined as follows: 6 weeks (6W), 1-60 days; 3 months (3M), 61-120 days; 6 months (6M), 121-225 days; 9 months (9M), 226-315 days; 1 year (1Y) >316 days. Analysis was performed using the SAS package (version 6.2) and a p-value of 0.05 or less was considered statistically significant. 
Results
Patient description
A total of thirty donor / recipient combinations were analyzed. All patients underwent an alloPBSCT from an HLA-matched related donor and were transplanted because of a hematological malignant disorder (Table 1) . Twenty-four of the recipients were studied in a longitudinal prospective analysis. One recipient was analyzed longitudinally from archival frozen material. Finally, five recipients were analyzed once at 1-1.5 years after alloPBSCT.
Hematopoietic reconstitution
At all sampling points, the absolute blood cell counts and the differential leukocyte counts of donors and recipients were determined. In combination with immunostaining and flow cytometric analysis, the absolute counts of leukocytes, granulocytes, monocytes, lymphocytes, B-cells (CD19+),
naive (CD4+/CD45RA+) and memory (CD4+/CD45RA-) helper T cells (T h ) and cytotoxic (CD8+) T cells (T c ) were determined (figure 1). Hematopoietic reconstitution of myeloid cells was relatively
rapid. At six weeks after transplantation the absolute counts of granulocytes and monocytes reached normal (donor) levels, implicating extensive proliferation in these cell fractions. The reconstitution of lymphocytes, initially depleted from the graft by Campath-1 incubation, was much slower. Even at one year after transplantation the lymphocyte counts were still below normal (figure 1A), in particular the T lymphocyte counts remained low (figure 1B). Within the T cell compartment, the T h cells reconstituted slower than the T c cells but blood cell counts for both T cell subfractions were still subnormal at one year after transplantation (figure 1C). Slow recovery was most pronounced for the naive T h cell subfraction ( figure 1D ). While in the donors the naive T cells comprised 49% of the T h cell compartment, this was only 18% for the recipients at one year after transplantation. The T cell numbers were reduced 6-fold compared to donor values at 6 weeks after transplantation. However, the B-cells, also initially depleted from the graft, showed remarkable high numbers at this first sampling time point after alloPBSCT, indicating considerable expansion in this cell fraction early after transplantation.
For personal use only. on July 16, 2017. by guest www.bloodjournal.org From
Telomere length analysis
Changes in the blood cell composition during reconstitution indicated differences in the replicative activity of the cell subsets. Therefore, the telomere lengths of the various cell subsets were analyzed separately. For all cell subsets tested, there was a large variation in the patterns of telomere length dynamics among individuals e.g. in some individuals dynamic telomere length changes were detected in all cell subsets (figure 2A,C) while in other individuals hardly any telomere length changes were measured during the follow-up period. The majority of the recipients showed an initial reduction of telomere length in the granulocytes followed by a period of telomere length increase ( figure 2A,C) .
However, in some individuals we could not detect such early dynamic changes (figure 2B). The overall analysis of all donor / recipient combinations revealed patterns of telomere length dynamics that were similar for granulocytes, monocytes (median subset purity 90%, range 75-99%) and B-cells (median subset purity 87%, range 75 -97%) i.e. a reduction of telomere length immediately after transplantation, followed by an increase in telomere length to such an extent that within the follow-up period of one year homeostasis was reached ( figure 3 ). The reduction of telomere length compared to the donor was statistically significant for both the granulocytes and the B-cells. The naive T h cells could not be analyzed within the first six months after transplantation due to low cell counts. The telomere lengths of the naive T h populations at one year after transplantation (median subset purity 95%, range 95 -99%) were comparable to those of the donors ( figure 3 ). The memory T h cells (median subset purity 95%, range 75 -99%), showed a completely different pattern of telomere length dynamics i.e. an increase in telomere length that reached statistical significance in the time period of 6 weeks to 9 months after transplantation ( figure 3) . At 1 year after transplantation also the telomere length of this cell population was not different anymore from telomere length in donor derived cells.
No correlation was found between telomere length dynamics and the number of transplanted CD34 + cells or the number of CFU-GMs (data not shown).
For
Discussion
We have shown dynamic telomere length changes in various hematopoietic cell subsets during the immediate reconstitution period after alloPBSCT. Although large differences in telomere length changes after transplantation were observed between individuals, the overall analysis revealed a distinct pattern of telomere length dynamics. Granulocytes, monocytes and B cells showed an initial decrease in length followed by an increase in telomere length within 1 year after transplantation. The telomere lengths of the memory T h cells from the recipients were longer than those from the donors during this time period until the telomere lengths of these recipient and donor cell populations could not be distinguished at 1 year after transplantation. Therefore, our data strongly indicate telomere length homeostasis and provide no evidence that the telomere length of the long term repopulating stem cell population is compromised by transplantation-induced replicative stress.
Reduction of telomere length has been reported after BMT in both granulocytes, monocytes and lymphocytes 5-9;13-15 . However, these reductions in telomere length found up to several years after transplantation persisted for decades [10] [11] [12] . The extent of telomere length reduction measured several years or decades after BMT was similar in these cross-sectional analyses. The observations were interpreted to indicate a limited reduction in the telomere length of the transplanted hematopoietic stem cells, due to the excessive replicative stress from the expansion after transplantation, followed by stabilization of the transplantation-related stem cell telomere shortening.
Our data on telomere dynamics after PBSCT and available data after BMT are similar with respect to the immediate short-term consequences. However, following an initial decrease in telomere length (in all subsets except the memory T h cells) we observed telomere lengthening during the first year after transplantation. This was most pronounced in the granulocytes, a cell population believed to reflect stem cell turnover. Our data are compatible with homeostasis of telomere length rather than with transplantation-related shortening. As a consequence, our data do not forecast a reduction of telomere length at mid-long term after alloPBSCT. The apparent discrepancy between published reports indicating a persistent reduction in telomere length and our study showing telomere length homeostasis may be explained by differences in the number of stem cells transplanted. While previously published reports deal with bone marrow, our analysis comprises cytokine-mobilized An increase in telomere length, as found in our study, can also be explained by induction of telomerase expression. Low levels of telomerase activity have been detected in hematopoietic cells and induction of telomerase has been observed in peripheral hematopoietic cell fractions [28] [29] [30] [31] [32] . However, in spite of telomerase upregulation, telomere shortening occurred [32] [33] [34] . Although a contribution of telomerase expression to telomere length homeostasis cannot be ruled out, we consider telomerase activation unlikely to be the single explanation for the observed telomere lengthening.
We observed an extremely slow reconstitution of naive T h cells (CD4+/CD45RA+). T-cell reconstitution after chemotherapy and after T-cell depleted BMT has been shown to be slow and age related and has been suggested to be dependent on the functionality of the thymus 35;36 . Naive T-cell generation by the thymus might be rate limiting in the regeneration of the T cell compartment.
For personal use only. on July 16, 2017. by guest www.bloodjournal.org From Furthermore, a large part of the naive T cell compartment is activated and recruited by the memory and effector T-cell compartments, especially in the setting of an allogeneic transplantation. This also reduces the recovery of the naive T cell compartment. The telomere length of the naive T h cell populations that were found in the recipients at 1 year after transplantation were similar to those in the donor, suggesting de novo generation rather than peripheral expansion of this cell population. The memory T h cell populations show a long lasting (statistically significant up to 9 months after transplantation) increase in telomere length. At 6 weeks after transplantation, few naive T h cells could be detected in the recipient, but there was a substantial number of memory T h cells, most likely comprising a mixture of expanded memory T h cells and memory T h cells derived from naive T h cells that were recruited by antigen activation. Since naive T h cells have longer telomeres than memory T h cells 37 (median telomere length of naive and memory T h cells in the healthy donors in our study equals 6.5 kb and 5.5 kb, respectively, data not shown), a simultaneous antigen recruitment of naive T h cells into the memory T h cell population might explain the increase in the telomere length of the memory T h cell population. This phenomenon has also been described in 3 out of 4 patients after BMT 13 .
The STR analyses that we performed on recipient granulocyte or MNC fractions showed complete or near complete (median >95%, data not shown) donor chimerism. However, in those cases where recipient cells could be detected, partial chimerism with a substantial recipient component was frequently detected in the memory T h cells fraction. E.g. one recipient with 95% donor chimerism in the BM WBC fraction showed only 52% donor chimerism in the memory T h fraction, in another individual exhibiting 85% donor chimerism in the BM WBC fraction only 18% of the memory T h fraction was of donor origin. Since the cells from these HLA-matched donors and recipients cannot be separated, this phenomenon prevented determination of the telomere length of the donor cells in the recipient in a number of cases. Our data show that an appropriate study of telomere length kinetics following (in particular T cell-depleted) allogeneic stem cell transplantation should include analysis of cell subsets and chimerism analysis, as significant differences in the levels of chimerism can be observed between T h cells and other cell fractions.
In conclusion our data show no permanent telomere length reduction after PBSCT and points towards telomere length homeostasis. This indicates that the telomere length of the stem cell pool has not been compromised, rendering graft failure due to telomere shortening an unlikely possibility.
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